SCHEDULE 13G/A: RA Capital Management Affiliates Disclose 3.1% Passive Stake in Evolent Health
Amendment to Beneficial Ownership Statement
RA Capital Management, along with Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P., have filed an amended Schedule 13G disclosing a 3.1% beneficial ownership stake in Evolent Health, Inc. as of December 31, 2024.
Summary
- RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G.
- The filing pertains to their beneficial ownership of Class A Common Stock, par value $0.01 per share, of Evolent Health, Inc.
- As of December 31, 2024, the Reporting Persons collectively beneficially own 3,577,197 shares of Evolent Health, Inc. Class A Common Stock.
- This aggregate amount represents 3.1% of the Issuer's Class A Common Stock outstanding.
- The percentage is calculated based on 116,563,910 shares of Class A Common Stock outstanding as of November 1, 2024, as reported in Evolent Health's Form 10-Q filed on November 8, 2024.
- The filing explicitly states that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
- RA Capital Healthcare Fund, L.P. directly holds the 3,577,197 shares, with RA Capital Management, L.P. serving as the investment adviser and having sole power to vote and dispose of these securities.
- Peter Kolchinsky and Rajeev Shah are controlling persons of RA Capital Management GP, LLC, the general partner of RA Capital, and may be deemed beneficial owners.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
This filing reflects a passive investment by a healthcare-focused investment firm, RA Capital Management, in Evolent Health, a company operating in the healthcare sector. Such disclosures are routine for institutional investors holding significant, non-controlling stakes in public companies.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's passive stake, confirming no intent to influence control.
Key Dates
| Date | Description |
|---|---|
| 2024-11-01 | Date as of which 116,563,910 shares of Issuer's Class A Common Stock were reported outstanding in the Issuer's Form 10-Q. |
| 2024-11-08 | Date Evolent Health, Inc. filed its Quarterly Report on Form 10-Q with the SEC. |
| 2024-12-31 | Date of event which requires filing of this statement (beneficial ownership snapshot date). |
| 2025-02-14 | Date the Joint Filing Agreement was executed and the Schedule 13G/A was signed and filed. |
Keywords
Evolent Health, RA Capital Management, Schedule 13G/A, Beneficial Ownership, Class A Common Stock, Institutional Investor, Healthcare Investment, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.